A weight-loss research peptide. Live vendor vial prices, sorted lowest first.
For research use only. Not for human consumption. No health, dosing, or usage claims are made.
AOD-9604 is a synthetic modified fragment of the C-terminal region of human growth hormone with an added N-terminal tyrosine. It is not an FDA-approved drug and is sold only as a research chemical.
AOD-9604 is the hGH(176-191) fragment with an added N-terminal tyrosine; it differs from plain HGH Fragment 176-191 by that extra Tyr residue. On-file CAS 221231-10-3 matches PubChem.
Regulatory status: As of 2026, AOD-9604 is not FDA-approved; it was nominated for the compounding bulk-substances list and placed in Category 2, but that nomination was later withdrawn by the nominator, with FDA citing limited safety information (FDA Category 2 page, current as of 04/22/2026).
Typical vendor vial prices, Jul 2026. Exact prices load with verified listings.
| Vendor | Vial price | |
|---|---|---|
Simple Peptide | $0.05Best | View vendor › |
Precision Research Peptides | $0.13 | View vendor › |
Prime Lab Peptides | $0.16 | View vendor › |
Koi Peptides | $0.18 | View vendor › |
Protide Health | $0.20 | View vendor › |
BioInfinity Lab | $0.22 | View vendor › |
Kaia Peptides | $0.33 | View vendor › |
BioLongevity Labs | $0.50 | View vendor › |
Mile High Compounds | $1 | View vendor › |
PSPeptides | $3.60 | View vendor › |
Skye Peptides | $8.80 | View vendor › |
Examined in cell and animal models of lipid metabolism; this reflects laboratory research and not a demonstrated effect in people.
Planning a reconstitution? Use the calculator — it is math for handling a vial, not dosing.
Sources & further reading: PubChem CID 71300630 (NCBI) · FDA — Bulk Drug Substances That May Present Significant Safety Risks (Category 2)
How we source this ›